ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1029

Fibroblast-like Synoviocytes As Immune Effectors in the Pathogenesis of Synovial Lesion in Antibiotic-Refractory Lyme Arthritis

Klemen Strle1, Robert Lochhead2, Ruslan Sadreyev3, Allen C. Steere4 and John Aversa5, 1Department of Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, BOSTON, MA, 2Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, BOSTON, MA, 3Department of Molecular Biology, Massachusetts General Hospital, Boston, MA, 4Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 5Orthopaedics and Rehabilitation, Yale Medical Group , Yale University School of Medicine, New Haven, CT

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Autoimmunity, Fibroblasts, inflammation and synovitis, Lyme disease

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Innate Immunity Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Antibiotic-refractory Lyme arthritis (LA) is characterized by marked proliferative synovitis that persists for months-to-years after oral and IV antibiotic therapy for Borrelia burgdorferi. Although the infection serves as the initial trigger for LA, the processes that that shape the post-antibiotic phase of refractory LA are incompletely understood. Herein we assessed the role of fibroblast-like synoviocytes (FLS), the predominant cell type in synovial lesion, in modulating the responses to infection with highly virulent B. burgdorferi RST1 strain and the prototypical Th1 effector cytokine, IFNγ; the key microbial and immune factors in antibiotic-refractory LA.

Methods: FLS were derived from synovia of antibiotic-refractory LA patients undergoing arthroscopic synovectomies. Low passage FLS were stimulated with B. burgdorferi, IFNγ, or a combination for 16h. After stimulation, genome-wide transcriptome profiles were assessed using RNASeq and protein levels of inflammatory mediators were measured using Luminex.

Results:

FLS sense and respond to B. burgdorferi by upregulating the expression of 68 genes associated primarily with pathogen sensing and innate immune responses, such as TLR2, NOD2, IL-1β, and IL-6. In contrast, stimulation with IFNγ leads to marked upregulation >2000 genes involved in pathways associated with immune dysregulation, cancer, and autoimmunity. These responses were amplified in FLS costimulated with B. burgdorferi and IFNγ which acted in synergistic fashion to induce a unique signature of differentially expressed genes that most closely resembled the transcriptome profiles in patients’ synovial tissue, including high upregulation of antigen-presenting molecules (HLA-DR, CIITA, CD40, and PD-L1; P<1×10-12). Moreover, cytokine and chemokine protein profiles secreted by FLS in response to costimulation, mimicked those in synovial fluid and tissue from patients with antibiotic-refractory LA, linking FLS to excessive inflammation in the joint.

Conclusion:

FLS play an important role in arthritis pathogenesis by initially shaping the immune responses to B. burgdorferi infection, and later by perpetuating dysregulated inflammatory responses in patients with antibiotic-refractory LA by responding to inflammatory milieu in the joint. The highly-activated state of FLS, including antigen-presentation, suggests an immune effector function of these cells even in the post-infectious period. These findings help explain how the initial host-pathogen interactions such as infection with an RST1 strain in patients with a TLR1-1805GG SNP, which lead to excessive IFNγ responses, may contribute to synovial hypertrophy and dysregulated immunity in the post-antibiotic period when few if any intact spirochetes remain.


Disclosure: K. Strle, None; R. Lochhead, None; R. Sadreyev, None; A. C. Steere, None; J. Aversa, None.

To cite this abstract in AMA style:

Strle K, Lochhead R, Sadreyev R, Steere AC, Aversa J. Fibroblast-like Synoviocytes As Immune Effectors in the Pathogenesis of Synovial Lesion in Antibiotic-Refractory Lyme Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/fibroblast-like-synoviocytes-as-immune-effectors-in-the-pathogenesis-of-synovial-lesion-in-antibiotic-refractory-lyme-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fibroblast-like-synoviocytes-as-immune-effectors-in-the-pathogenesis-of-synovial-lesion-in-antibiotic-refractory-lyme-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology